Floating from the east along 17th St. in north Arlington, the graceful Mississippi kite flew into one of the large oak trees on the northeast corner of 17th and Utah. with food for its now quite large ...
Gilead’s $11.9 billion purchase of Kite Pharma in 2017 didn’t follow the script, with two big write-downs in the value of the asset since then, but a fresh approval for a CAR-T therapy could claw back ...
NHS patients in England will be among the first in the world to receive Gilead’s Tecartus cancer cell therapy for certain types of lymphoma, after the company’s specialist Kite unit struck a deal with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback